All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ2045 | Anti-SCP2 (CBXS-3973) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-3973 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2046 | Anti-SCP2 (CBXS-4061) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4061 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2047 | Anti-SCP2 (CBXS-4898) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4898 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2048 | Anti-SCP2 (CBXS-4937) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4937 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2049 | Anti-SCP2 (CBXS-1622) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBXS-1622 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2050 | Anti-SCP2 (CBXS-2900) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2900 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5469 | Anti-SCP2 (CBXS-3973) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-3973 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5470 | Anti-SCP2 (CBXS-4061) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4061 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5471 | Anti-SCP2 (CBXS-4898) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4898 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5472 | Anti-SCP2 (CBXS-4937) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4937 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5473 | Anti-SCP2 (CBXS-1622) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBXS-1622 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5474 | Anti-SCP2 (CBXS-2900) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2900 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION